PE20060768A1 - Composicion farmaceutica que comprende hidroclorotiazida y telmisartano - Google Patents

Composicion farmaceutica que comprende hidroclorotiazida y telmisartano

Info

Publication number
PE20060768A1
PE20060768A1 PE2005001465A PE2005001465A PE20060768A1 PE 20060768 A1 PE20060768 A1 PE 20060768A1 PE 2005001465 A PE2005001465 A PE 2005001465A PE 2005001465 A PE2005001465 A PE 2005001465A PE 20060768 A1 PE20060768 A1 PE 20060768A1
Authority
PE
Peru
Prior art keywords
pharmaceutical composition
hydrochlorothiazide
composition including
telmisartane
composition
Prior art date
Application number
PE2005001465A
Other languages
English (en)
Inventor
Helmut E Schumacher
Axel Riedel
Peter Bohm
Original Assignee
Boehringer Ingelheim Int
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=35589356&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PE20060768(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Boehringer Ingelheim Int filed Critical Boehringer Ingelheim Int
Publication of PE20060768A1 publication Critical patent/PE20060768A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4184—1,3-Diazoles condensed with carbocyclic rings, e.g. benzimidazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/5415—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with carbocyclic ring systems, e.g. phenothiazine, chlorpromazine, piroxicam
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
  • Medicinal Preparation (AREA)

Abstract

REFERIDA A UNA COMPOSICION FARMACEUTICA QUE COMPRENDE 80 MG DE UN ANTAGONISTA DEL RECEPTOR DE ANGIOTENSINA II TAL COMO EL TELMISARTANO Y 25 MG DE UN DIURETICO TAL COMO HIDROCLOROTIAZIDA. TAMBIEN ESTA REFERIDA A UNA COMPOSICION FARMACEUTICA QUE PUEDE DIVIDIRSE EN MITADES QUE COMPRENDE 160 MG DE TELMISARTANO Y 50 MG DE HIDROCLOROTIAZIDA. LA COMPOSICION PUEDE CONTENER, ADEMAS, HIDROXIDO DE SODIO, MEGLUMINA, POVIDONA, SORBITOL, ESTEARATO DE MAGNESIO, LACTOSA MONOHIDRATADA, CELULOSA MICROCRISTALINA, ALMIDON DE MAIZ, ENTRE OTROS. DICHA COMPOSICION ES UTIL PARA EL TRATAMIENTO DE LA HIPERTENSION, ACCIDENTES CEREBRO VASCULARES, INSUFICIENCIA CARDIACA CONGESTIVA, RESISTENCIA A LA INSULINA, ENTRE OTROS
PE2005001465A 2004-12-17 2005-12-15 Composicion farmaceutica que comprende hidroclorotiazida y telmisartano PE20060768A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US63706204P 2004-12-17 2004-12-17

Publications (1)

Publication Number Publication Date
PE20060768A1 true PE20060768A1 (es) 2006-09-29

Family

ID=35589356

Family Applications (1)

Application Number Title Priority Date Filing Date
PE2005001465A PE20060768A1 (es) 2004-12-17 2005-12-15 Composicion farmaceutica que comprende hidroclorotiazida y telmisartano

Country Status (15)

Country Link
EP (1) EP1827424A1 (es)
JP (1) JP2008524136A (es)
KR (1) KR20070097511A (es)
CN (1) CN101080225A (es)
AR (1) AR052052A1 (es)
AU (1) AU2005315855A1 (es)
BR (1) BRPI0519656A2 (es)
CA (1) CA2589493A1 (es)
EA (1) EA200701159A1 (es)
IL (1) IL183944A0 (es)
NO (1) NO20072325L (es)
PE (1) PE20060768A1 (es)
TW (1) TW200637546A (es)
UY (1) UY29274A1 (es)
WO (1) WO2006063737A1 (es)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7232828B2 (en) 2002-08-10 2007-06-19 Bethesda Pharmaceuticals, Inc. PPAR Ligands that do not cause fluid retention, edema or congestive heart failure
US8637078B2 (en) * 2005-11-24 2014-01-28 Boehringer Ingelheim International Gmbh Bilayer tablet comprising telmisartan and diuretic
EP1970053A1 (en) * 2007-03-14 2008-09-17 Boehringer Ingelheim Pharma GmbH & Co. KG Pharmaceutical composition
JP4879351B2 (ja) * 2007-10-19 2012-02-22 大塚製薬株式会社 医薬固形製剤
EP2203158A4 (en) 2007-10-30 2012-12-26 Reddys Lab Ltd Dr PHARMACEUTICAL FORMULATIONS WITH TELMISARTAN AND HYDROCHLORTHIAZIDE
WO2009115301A1 (en) 2008-03-19 2009-09-24 Ratiopharm Gmbh Solid pharmaceutical composition comprising a non-peptide angiotensin ii receptor antagonist and a diuretic
BRPI0916847A2 (pt) 2008-07-31 2016-02-10 Takeda Pharmaceutical preparação sólida, e, métodos para estabilizar um composto e para melhorar a propriedade de dissolução de um composto.
GB0822170D0 (en) * 2008-12-04 2009-01-14 Arrow Int Ltd Telmisartan with diuretic formulations
WO2010146187A2 (en) 2009-06-19 2010-12-23 Krka, Tovarna Zdravil, D.D., Novo Mesto Process for the preparation of telmisartan
WO2011002425A2 (en) * 2009-07-02 2011-01-06 Bilgig Mahmut Pharmaceutical composition increasing solubility and stability
WO2011002423A2 (en) * 2009-07-02 2011-01-06 Mahmut Bilgic Solubility enhancing pharmaceutical composition
TR200906506A2 (tr) 2009-08-24 2011-03-21 Bi̇lgi̇ç Mahmut Telmisartan içeren katı dozaj formları.
WO2011161123A2 (en) 2010-06-21 2011-12-29 Krka, Tovarna Zdravil, D.D., Novo Mesto Multilayer pharmaceutical tablet comprising telmisartan and a diuretic
EP2952196A4 (en) * 2013-01-31 2016-08-03 Sawai Seiyaku Kk MULTILAYER TABLET CONTAINING TELMISARTAN AND HYDROCHLOROTHIAZIDE
EP3025711B1 (en) * 2013-07-23 2020-11-18 Daiichi Sankyo Company, Limited Medicine for preventing or treating hypertension
CN106562973A (zh) * 2016-11-06 2017-04-19 成都先先先生物科技有限公司 一种抗高血压药物复方制剂
CN107501192A (zh) * 2017-08-15 2017-12-22 中国科学院上海药物研究所 替米沙坦与氢氯噻嗪的共晶
CN108653227A (zh) * 2018-08-09 2018-10-16 湖北舒邦药业有限公司 一种替米沙坦氢氯噻嗪片及其制备方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4229085C2 (de) * 1992-09-01 1996-07-11 Boehringer Mannheim Gmbh Längliche, teilbare Tablette
ATE380547T1 (de) * 2002-01-16 2007-12-15 Boehringer Ingelheim Pharma Zweischichtige pharmazeutische tablette enthaltend telmisartan und hydrochlorothiazid

Also Published As

Publication number Publication date
JP2008524136A (ja) 2008-07-10
EP1827424A1 (en) 2007-09-05
BRPI0519656A2 (pt) 2009-03-03
KR20070097511A (ko) 2007-10-04
CN101080225A (zh) 2007-11-28
AR052052A1 (es) 2007-02-28
AU2005315855A1 (en) 2006-06-22
TW200637546A (en) 2006-11-01
UY29274A1 (es) 2006-07-31
EA200701159A1 (ru) 2007-12-28
CA2589493A1 (en) 2006-06-22
NO20072325L (no) 2007-07-06
WO2006063737A1 (en) 2006-06-22
IL183944A0 (en) 2007-10-31

Similar Documents

Publication Publication Date Title
PE20060768A1 (es) Composicion farmaceutica que comprende hidroclorotiazida y telmisartano
CL2008003595A1 (es) Compuestos heterociclicos nitrogenados, antagonistas del receptor de taquiquinina; agente farmaceutico que comprende el compuesto; y uso en la profilaxis o el tratamiento de una enfermedad del tracto urinario inferior, una enfermedad gastrointestinal o una enfermedad del sistema nervioso central.
UA86831C2 (uk) Композиція таблетки пролонгованого вивільнення, яка містить праміпексол або його фармацевтично прийнятну сіль, спосіб її виготовлення та її застосування
BRPI0507887A (pt) comprimido de múltiplas camadas
AR087210A2 (es) Formulacion farmaceutica de la sal sodica del telmisartan
PE20061449A1 (es) Composiciones farmaceuticas comprendiendo imatinib y un retardador de liberacion
WO2011014587A3 (en) Ophthalmic pharmaceutical compositions of dp2 receptor antagonists
PA8849701A1 (es) Forma de dosificacion farmaceutica que comprende nifedipino o nisoldipino y un antagonista de anglotensina ii y/o un diuretico
PE20020082A1 (es) Composicion farmaceutica que comprende un inhibidor de aldosterona-sintasa y un antagonista del receptor de angiotensina ii (at1)
ATE415947T1 (de) Verwendung von stärke mit abgespaltenen seitenketten in der extrudierung / spheronisierung von pharmazeutischen pellets
EA201001312A1 (ru) Твердая фармацевтическая композиция, содержащая непептидный антагонист рецептора ангиотензина ii и диуретик
PE20061195A1 (es) Derivado de bencimidazol como antagonista de angiotensina ii
PE20141049A1 (es) Composicion farmaceutica antihipertensiva
PE20121131A1 (es) Composicion farmaceutica oral solida en comprimido monocapa que comprende irbesartan y besilato de amlodipina
AR066168A1 (es) Formulaciones galenicas de compuestos organicos
UY30461A1 (es) Composicion farmacéutica para la anticoncepcion y para reducir el riesgo de malformaciones congénitas.
EP2540294A4 (en) SOLID PREPARATION WITH DELAYED RELEASE FOR ORAL ADMINISTRATION
UY30046A1 (es) Nuevos derivados de furopirimidina acíclicos sustitiudos y su uso
AR061233A1 (es) Formulacion de liberacion prolongada de naltrexona
DE602008000367D1 (de) Valsartanformulierungen
PE20120421A1 (es) Composicion farmaceutica que comprende aleglitazar
PE20020617A1 (es) Composicion que comprende un antagonista del receptor at1 y un potenciador de la secrecion de insulina o un sensibilizante a la insulina
CL2009000896A1 (es) Compuestos derivados de 3-fenilpirazolo[5,1-b]tiazol sustituido; composicion farmaceutica; utiles en el tratamiento de la depresion, ansiedad, isquemia, apoplejia, hipertension, esquizofrenia, entre otras enfermedades.
AR048970A1 (es) Formulacion farmaceutica solida
PE20090675A1 (es) Composicion farmaceutica que contie levosimendan y un antagonista receptor de angiotensina ii o un inhibidor eca

Legal Events

Date Code Title Description
FC Refusal